Somatic TP53 Mutations Are Relatively Rare among Adrenocortical Cancers with the Frequent 17p13 Loss of Heterozygosity

Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome

Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308 · see citing works

The codon 72 polymorphic variants of p53 have markedly different apoptotic potential

Dumont, P., Leu, J. I.-J., Pietra, A. D., George, D. L., & Murphy, M. E. (2003) · Nature Genetics · doi:10.1038/ng1093 · Cited by 1,269 · see citing works

Comparative histologic study of 43 metastasizing and nonmetastasizing adrenocortical tumors

Weiss, L. M. (1984) · The American Journal of Surgical Pathology · doi:10.1097/00000478-198403000-00001 · Cited by 920 · see citing works

Adrenocortical Carcinoma: Clinical Update

Allolio, B., & Fassnacht, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2639 · Cited by 775 · see citing works

Multiple Primary Cancers in Families With Li-Fraumeni Syndrome

Hisada, M., Garber, J. E., Li, F. P., Fung, C. Y., & Fraumeni, J. F. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.8.606 · Cited by 553 · see citing works

An inherited <i>p53</i> mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma

Ribeiro, R. C., Sandrini, F., Figueiredo, B., Zambetti, G. P., Michalkiewicz, E., Lafferty, A. R., DeLacerda, L., Rabin, M., Cadwell, C., Sampaio, G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.161479898 · Cited by 541 · see citing works

Mutations of <i>β-Catenin</i> in Adrenocortical Tumors: Activation of the Wnt Signaling Pathway Is a Frequent Event in both Benign and Malignant Adrenocortical Tumors

Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474 · see citing works

Clinical and biological features in the prognosis of adrenocortical cancer: poor outcome of cortisol-secreting tumors in a series of 202 consecutive patients

Abiven, G., Coste, J., Groussin, L., Anract, P., Tissier, F., Legmann, P., Dousset, B., Bertagna, X., & Bertherat, J. (2006) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2005-2730 · Cited by 435 · see citing works

Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors.

Gicquel, C., BERTAGNA, X. Y., Gaston, V., Coste, J., Louvel, A., Baudin, É., Bertherat, J. Y., Chapuis, Y., Duclos, J. M., Schlumberger, M. J., et al. (2001) · PubMed · Cited by 285 · see citing works

Cancer of the adrenal cortex; the natural history, prognosis and treatment in a study of fifty-five cases.

Macfarlane, D. A. (1958) · PubMed · Cited by 266 · see citing works

Are there low-penetrance TP53 alleles? Evidence from childhood adrenocortical tumors

Varley, J. M., McGown, G., Thorncroft, M., James, L. A., Margison, G. P., Forster, G., Evans, D. G. R., Harris, M., Kelsey, A. M., & Birch, J. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302575 · Cited by 266 · see citing works

TP53 and gastric carcinoma: A review

Fenoglio‐Preiser, C. M., Wang, J., Stemmermann, G. N., & Noffsinger, A. E. (2003) · Human Mutation · doi:10.1002/humu.10180 · Cited by 252 · see citing works

Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.

Bertherat, J. Y., Groussin, L., Sandrini, F., Matyakhina, L., Bei, T. A., Stergiopoulos, S. G., Papageorgiou, T., Bourdeau, I., Kirschner, L. S., Vincent-Dejean, C., et al. (2003) · PubMed · Cited by 250 · see citing works

p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies

Reincke, M., Karl, M., Travis, W. H., Mastorakos, G. P., Allolio, B., Linehan, H. M., & Chrousos, G. P. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.3.8126158 · Cited by 228 · see citing works

High frequency of germline p53 mutations in childhood adrenocortical cancer

Wagner, J., Portwine, C., Rabin, K., Leclerc, J.-M., Narod, S. A., & Malkin, D. (1994) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/86.22.1707 · Cited by 227 · see citing works

An inherited mutation outside the highly conserved DNA-binding domain of the p53 tumor suppressor protein in children and adults with sporadic adrenocortical tumors

Latronico, A. C., Pinto, E. M., Domenice, S., Fragoso, M. C. B. V., Martin, R. M., Zerbini, M. C., Lucon, A. M., & Mendonca, B. B. (2001) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jcem.86.10.7957 · Cited by 224 · see citing works

Rearrangements at the 11p15 locus and overexpression of insulin-like growth factor-II gene in sporadic adrenocortical tumors

Gicquel, C., BERTAGNA, X. Y., Schneid, H., Leblond‐Francillard, M., LUTON, J. P., Girard, F., & Bouc, Y. L. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7911125 · Cited by 224 · see citing works

Molecular markers of prostate cancer outcome

Quinn, D. I., Henshall, S. M., & Sutherland, R. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.035 · Cited by 191 · see citing works

Molecular genetics of adrenocortical tumours, from familial to sporadic diseases

Libé, R., & Bertherat, J. (2005) · European Journal of Endocrinology · doi:10.1530/eje.1.02004 · Cited by 168 · see citing works

TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis

Matakidou, A. (2003) · Mutagenesis · doi:10.1093/mutage/geg008 · Cited by 150 · see citing works

p53 Codon 72 Polymorphism and Cervical Neoplasia

Koushik, A., Platt, R. W., & Franco, E. L. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-083-3 · Cited by 146 · see citing works

Comparative Genomic Hybridization Analysis of Adrenocortical Tumors

Sidhu, S. B., Marsh, D. J., Theodosopoulos, G., Philips, J. N., Bambach, C. P., Campbell, P. R., Magarey, C. J., Russell, C. F. J., Schulte, K., Röher, H. D., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8697 · Cited by 144 · see citing works

<i>p53</i> Mutations in sporadic adrenocortical tumors

Ohgaki, H., Kleihues, P., & Heitz, P. U. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910540310 · Cited by 139 · see citing works

Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer.

Chen, L., Neubauer, A., Kurisu, W., Waldman, F. M., Ljung, B., Goodson, W. H., Goldman, E. S., Moore, D. H., Balázs, M., & Liu, E. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3847 · Cited by 138 · see citing works

Determination of TP53 Mutation Is More Relevant Than Microsatellite Instability Status for the Prediction of Disease-Free Survival in Adjuvant-Treated Stage III Colon Cancer Patients

Westra, J. L., Schaapveld, M., Hollema, H., de Boer, J. P., Kraak, M. M. J., de Jong, D., ter Elst, A., Mulder, N. H., Buys, C. H. C. M., Hofstra, R. M. W., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.096 · Cited by 133 · see citing works

p53 Codon 72 Polymorphism as a Risk Factor in the Development of Breast Cancer

Papadakis, E. N., Dokianakis, D. N., & Spandidos, D. A. (2000) · Molecular Cell Biology Research Communications · doi:10.1006/mcbr.2000.0241 · Cited by 126 · see citing works

p53 overexpression and mutation in metaplastic carcinoma of the breast: genetic evidence for a monoclonal origin of both the carcinomatous and the heterogeneous sarcomatous components

Lien, H., Lin, C., Mao, T., Kuo, S., Hsiao, C.-H., & Huang, C. (2004) · The Journal of Pathology · doi:10.1002/path.1624 · Cited by 123 · see citing works

Mutations of the p53 gene in human functional adrenal neoplasms.

Lin, S. R., Lee, Y. J., & Tsai, J. H. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.8106638 · Cited by 112 · see citing works

TP53 promoter methylation in human gliomas

Amatya, V. J., Naumann, U., Weller, M., & Ohgaki, H. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1041-5 · Cited by 99 · see citing works

Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors

Barzon, L., Chilosi, M., Fallo, F., Martignoni, G., Montagna, L., Palu, G., & Boscaro, M. (2001) · European Journal of Endocrinology · doi:10.1530/eje.0.1450207 · Cited by 94 · see citing works

Mutation and expression of the TP53 gene in early stage epithelial ovarian carcinoma

LEITAO, M., Soslow, R. A., Baergen, R. N., Olvera, N., ARROYO, C., & Boyd, J. A. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.01.043 · Cited by 88 · see citing works

Molecular biology of sporadic gastric cancer: prognostic indicators and novel therapeutic approaches

Scartozzi, M., Galizia, G., Freddari, F., Berardi, R., Cellerino, R., & Cascinu, S. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.01.001 · Cited by 70 · see citing works

TP53 is frequently altered by methylation, mutation, and/or deletion in acute lymphoblastic leukaemia

Agirre, X., Novo, F. J., Calasanz, M. J., Larráyoz, M. J., Lahortiga, I., Valgañón, M., García‐Delgado, M., & Vizmanos, J. L. (2003) · Molecular Carcinogenesis · doi:10.1002/mc.10159 · Cited by 69 · see citing works

Aberrant methylation of multiple genes in neuroblastic tumours

González‐Gómez, P., Bello, M. J., Lomas, J. S., Arjona, D., Alonso, M. E., Amiñoso, C., Lopez-Marín, I., Anselmo, N. P., Sarasa, J. L., Gutierrez, M., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00312-5 · Cited by 67 · see citing works

p53 mutation analysis for definite diagnosis of multiple primary lung carcinoma

van Rens, M. T. M., Eijken, E. J. E., Elbers, J. R. J., et al. (2001) · Cancer · doi:10.1002/cncr.10001 · Cited by 66 · see citing works

Methylation profile of the promoter CpG islands of 14 “drug-resistance” genes in hepatocellular carcinoma

Ding, S. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i23.3433 · Cited by 61 · see citing works

New insights into p53 protein stabilisation in oral squamous cell carcinoma

Partridge, M., Kiguwa, S., Emilion, G., Pateromichelakis, S., A’Hern, R., & Langdon, J. (1999) · Oral Oncology · doi:10.1016/s1368-8375(98)00051-7 · Cited by 51 · see citing works

Mutation and methylation analysis of TP53 in adrenal carcinogenesis

Sidhu, S., Martin, E. W., Gicquel, C., Melki, J. R., Clark, S. J., Campbell, P., Magarey, C. J., Schulte, K., Röher, H.-D., Delbridge, L., et al. (2005) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2005.01.013 · Cited by 49 · see citing works

p53 mutations in adrenal tumors: Caucasian patients do not show the exon 4 "hot spot" found in Taiwan

Reincke, M., Wachenfeld, C., Mora, P., THUMSER, A. E. A., Jaursch-Hancke, C., Abdelhamid, S., Chrousos, G. P., & Allolio, B. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855814 · Cited by 46 · see citing works

Deletion Mapping of Chromosome 17 in Benign and Malignant Adrenocortical Tumors Associated with the Arg337His Mutation of the p53 Tumor Suppressor Protein

Pinto, E. M., Billerbeck, A. E. C., Fragoso, M. C. B. V., Mendonca, B. B., & Latronico, A. C. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0963 · Cited by 42 · see citing works

Molecular prognostication in bladder cancer—a current perspective

Quek, M. L., Quinn, D. I., Daneshmand, S., & Stein, J. P. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00300-9 · Cited by 42 · see citing works

Promoter methylation status of multiple genes in brain metastases of solid tumors

González‐Gómez, P., Bello, M., Alonso, M., et al. (2004) · International Journal of Molecular Medicine · doi:10.3892/ijmm.13.1.93 · Cited by 35 · see citing works

Deletions of 17p are associated with transition from early to advanced colorectal cancer

Risio, M., Casorzo, L., Chiecchio, L., Rosa, G. D., & Rossini, F. P. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(03)00188-2 · Cited by 35 · see citing works

p53 protein overexpression and p53 mutation analysis in patients with intestinal metaplasia of the cardia and Barrett's esophagus

Segal, F., Kaspary, A. P. B., Prolla, J. C., et al. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.01.020 · Cited by 23 · see citing works

Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene

Liscia, D. S., Morizio, R., Venesio, T., Palenzona, C., Donadio, M., & Callahan, R. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690427 · Cited by 22 · see citing works

Evidence for another tumor suppressor gene at 17p13.3 distal to TP53 in hepatocellular carcinoma

Guan, X., Sham, J. S. T., Tai, L.-S., Fang, Y., Li, H., & Liang, Q. (2003) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(02)00654-4 · Cited by 22 · see citing works

Hyaluronan synthases, hyaluronan, and its CD44 receptor in tissue around loosened total hip prostheses

Konttinen, Y. T., Li, T.-F., Mandelin, J., Ainola, M., Lassus, J., Virtanen, I., Santavirta, S. S., Tammi, M., & Tammi, R. (2001) · The Journal of Pathology · doi:10.1002/1096-9896(200107)194:3 · Cited by 20 · see citing works

DETECTION OF LOSS OF HETEROZYGOSITY IN THE P53 TUMOR-SUPPRESSOR GENE WITH PCR IN THE URINE OF PATIENTS WITH BLADDER CANCER

Friedrich, M. G., Erbersdobler, A., Schwaibold, H. E., et al. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67878-0 · Cited by 17 · see citing works

p53 as a prognostic factor in adrenocortical tumors of adults and children

Sredni, S. T., Zerbini, M. C. N., Latorre, M. R. D. O., & Alves, V. A. F. (2003) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2003000100004 · Cited by 15 · see citing works

TP53 mutations are associated with a particular pattern of genomic imbalances in breast carcinomas

Sahlberg, K. K., Diep, C. B., Pandis, N., et al. (2005) · The Journal of Pathology · doi:10.1002/path.1812 · Cited by 9 · see citing works

<i>ARMC5</i>Mutations in Macronodular Adrenal Hyperplasia with Cushing's Syndrome

Assié, G., Libé, R., Espiard, S., Rizk-Rabin, M., Guimier, A., Luscap, W., Barreau, O., Lefèvre, L., Sibony, M., Guignat, L., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1304603 · Cited by 395 · see citing works

Adrenocortical carcinoma: a clinician’s update

Fassnacht, M., Libé, R., Kroiss, M., & Allolio, B. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.235 · Cited by 396 · see citing works

Adrenal incidentaloma

Sherlock, M., Scarsbrook, A., Abbas, A., Fraser, S., Limumpornpetch, P., Dineen, R., & Stewart, P. M. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa008 · Cited by 347 · see citing works

Development of adrenal cortex zonation

Xing, Y., Lerario, A. M., Rainey, W., & Hammer, G. D. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.001 · Cited by 174 · see citing works

Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and β-catenin

Heaton, J. H., Wood, M. A., Kim, A. C., Lima, L. O., Barlaskar, F. M., Almeida, M. Q., Fragoso, M. C. B. V., Kuick, R., Lerario, A. M., Simon, D. P., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.05.026 · Cited by 173 · see citing works

Transcriptome analysis reveals that p53 and β-catenin alterations occur in a group of aggressive adrenocortical cancers

Ragazzon, B., Libé, R., Gaujoux, S., Assié, G., Fratticci, A., Launay, P., Clauser, E., Bertagna, X., Tissier, F., de Reyniès, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2014 · Cited by 152 · see citing works

β-Catenin activation is associated with specific clinical and pathologic characteristics and a poor outcome in adrenocortical carcinoma

Gaujoux, S., Grabar, S., Fassnacht, M., Ragazzon, B., Launay, P., Libé, R., Chokri, I., Audebourg, A., Royer, B., Sbiera, S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2006 · Cited by 146 · see citing works

Wnt/β-catenin and 3′,5′-cyclic adenosine 5′-monophosphate/protein kinase A signaling pathways alterations and somatic β-catenin gene mutations in the progression of adrenocortical tumors

Gaujoux, S., Tissier, F., Groussin, L., Libé, R., Ragazzon, B., Launay, P., Audebourg, A., Dousset, B., Bertagna, X., & Bertherat, J. (2008) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2008-0631 · Cited by 142 · see citing works

<i>TP53</i>Germline Mutations in Adult Patients with Adrenocortical Carcinoma

Herrmann, L. J. M., Heinze, B., Fassnacht, M., Willenberg, H. S., Quinkler, M., Reisch, N., Zink, M., Allolio, B., & Hahner, S. (2012) · The Journal of Clinical Endocrinology &amp; Metabolism · doi:10.1210/jc.2011-1982 · Cited by 109 · see citing works

Towards an understanding of the role of p53 in adrenocortical carcinogenesis

Wasserman, J. D., Zambetti, G. P., & Malkin, D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.010 · Cited by 84 · see citing works

Challenges in surgical pathology of adrenocortical tumours

Erickson, L. A. (2018) · Histopathology · doi:10.1111/his.13255 · Cited by 70 · see citing works

Molecular epidemiology of adrenocortical tumors in southern Brazil

Custódio, G., Komechen, H., Figueiredo, F. R. O., Fachin, N. D., Pianovski, M. A. D., & Figueiredo, B. C. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.019 · Cited by 63 · see citing works

Pathology of the adrenal cortex: a reappraisal of the past 25 years focusing on adrenal cortical tumors

Papotti, M., Duregon, E., Volante, M., & McNicol, A. M. (2014) · Endocrine Pathology · doi:10.1007/s12022-013-9291-6 · Cited by 33 · see citing works

Genetics of Zoarces populations I. Three loci determining the phosphoglucomutase isoenzymes in brain tissue

Hjorth, J. P. (2009) · Hereditas · doi:10.1111/j.1601-5223.1971.tb02438.x · Cited by 47 · see citing works

Population variation at the polymorphic ApaLI restriction enzyme site in intron 5 of the WT1 gene

Besnard‐Guérin, C., Winqvist, R., Newsham, I., et al. (1996) · Clinical Genetics · doi:10.1111/j.1399-0004.1996.tb02738.x

Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers.

Huang, Y., Boynton, R. F., Blount, P. L., et al. (1992) · PubMed · Cited by 220 · see citing works

Carrier detection of hemophilia A in a Mexican population by two Bcl I polymorphisms.

Pérez, C., Fragoso Herrera, R., Cisneros Vega, B., et al. (1993) · PubMed

Combined polymorphism associated with a 3-bp deletion in the 5'-flanking region of a tetrameric short tandem repeat at the CYP19 locus.

Kurosaki, K., Saitoh, H., Oota, H., et al. (1997) · PubMed · Cited by 18 · see citing works